Skip to content

Advancing the Science of Pediatric Interstage Home Monitoring

Heart@Home: Advancing the Science of Pediatric Interstage Home Monitoring

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06547268
Acronym
Heart@Home
Enrollment
2
Registered
2024-08-09
Start date
2024-07-24
Completion date
2025-10-30
Last updated
2025-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Defects, Congenital

Keywords

Heart Defects, Congenital, Digital Health

Brief summary

The overall goal of this study is to understand the feasibility of using a wireless sensor device (instead of a wired device) to collect information used to monitor children with heart conditions at home.

Detailed description

The goal of this study is to examine how well continuous sensor-based monitoring performs at detecting physiologic data in infants with single ventricle physiology at home compared to existing approaches, in manner that is feasible and acceptable to patients' families. Performance features of interest include how the data compares to family measurements, whether it correlates with parents' observable symptoms, and how this approach may be integrated into home life and health system workflows. The investigators will also explore whether the collected data can be used to develop predictive analytics for acute deterioration and/or advanced chronic cardiopulmonary management compared to what is currently being done in remote patient monitoring.

Interventions

DEVICEWireless sensor and platform

Skin-mounted sensor that pairs with tablet platform

Sponsors

Sibel Health Inc.
CollaboratorINDUSTRY
Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 2 Years
Healthy volunteers
No

Inclusion criteria

* Receiving active remote patient monitoring (RPM) in Lurie's Tele-Interstage Home Monitoring Program. * Age 0-2 years of age at enrollment. * In the opinion of the investigator, parent or legally authorized guardian, and participant, the participant and (when relevant) family can follow study procedures.

Exclusion criteria

* Is going to discontinue RPM before their enrollment would end (i.e., within 14 days). * Skin breakdown or severe rash at the site of sensor placement. * Patient without a parental guardian to consent. * The patient is in active hospice or similar end-of-life care. * The patient will be living in a long-term institution or transitional facility.

Design outcomes

Primary

MeasureTime frameDescription
Physiologic measurementsup to 14 days per patient of data collectionPhysiologic data waveform morphology

Secondary

MeasureTime frameDescription
Systems Usability Scoreup to 14 days per patient of data collectionScore from 0 (min) to 100 (max) of usability with higher is better (100=perfect).
Utilizationup to 14 days per patient of data collectionEmergency departnment use

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026